266 related articles for article (PubMed ID: 32337786)
1. INI-1 (SMARCB1)-Deficient Undifferentiated Sinonasal Carcinoma: Novel Paradigm of Molecular Testing in the Diagnosis and Management of Sinonasal Malignancies.
Shaverdashvili K; Azimi-Nekoo E; Cohen P; Akbar N; Ow TJ; Halmos B; Castellucci E
Oncologist; 2020 Sep; 25(9):738-744. PubMed ID: 32337786
[TBL] [Abstract][Full Text] [Related]
2. SMARCB1 (INI-1)-deficient Sinonasal Carcinoma: A Series of 39 Cases Expanding the Morphologic and Clinicopathologic Spectrum of a Recently Described Entity.
Agaimy A; Hartmann A; Antonescu CR; Chiosea SI; El-Mofty SK; Geddert H; Iro H; Lewis JS; Märkl B; Mills SE; Riener MO; Robertson T; Sandison A; Semrau S; Simpson RH; Stelow E; Westra WH; Bishop JA
Am J Surg Pathol; 2017 Apr; 41(4):458-471. PubMed ID: 28291122
[TBL] [Abstract][Full Text] [Related]
3. Proceedings of the North American Society of Head and Neck Pathology, Los Angeles, CA, March 20, 2022: SWI/SNF-deficient Sinonasal Neoplasms: An Overview.
Agaimy A
Head Neck Pathol; 2022 Mar; 16(1):168-178. PubMed ID: 35307773
[TBL] [Abstract][Full Text] [Related]
4. SMARCB1 (INI-1)-deficient carcinomas of the sinonasal tract.
Bishop JA; Antonescu CR; Westra WH
Am J Surg Pathol; 2014 Sep; 38(9):1282-9. PubMed ID: 25007146
[TBL] [Abstract][Full Text] [Related]
5. SMARCA4-deficient Sinonasal Carcinoma.
Agaimy A; Weichert W
Head Neck Pathol; 2017 Dec; 11(4):541-545. PubMed ID: 28176137
[TBL] [Abstract][Full Text] [Related]
6. Metastatic SMARCB1 (INI-1)-Deficient Sinonasal Carcinoma Diagnosed by Endobronchial Ultrasound-Guided Fine-Needle Aspiration (EBUS-FNA): A Potential Diagnostic Pitfall and Review of the Literature.
McHugh KE; Policarpio-Nicolas MLC
Acta Cytol; 2019; 63(5):431-437. PubMed ID: 31132763
[TBL] [Abstract][Full Text] [Related]
7. SMARCB1 (INI-1) - Deficient sinonasal carcinoma: Report of two cases.
Vasudevan G; Srinivas SP; Nayal B; Jayaprakash P; Ramaswamy B
Indian J Pathol Microbiol; 2023; 66(2):352-355. PubMed ID: 37077082
[TBL] [Abstract][Full Text] [Related]
8. SMARCB1 (INI-1) and NUT immunoexpression in a large series of head and neck carcinomas in a Brazilian reference center.
Neves-Silva R; Almeida LY; Silveira HA; Colturato CBN; Duarte A; Ferrisse TM; Silva EV; Vanzolin BF; Bufalino A; Ribeiro-Silva A; León JE
Head Neck; 2020 Mar; 42(3):374-384. PubMed ID: 31729110
[TBL] [Abstract][Full Text] [Related]
9. Cytopathologic characteristics of SMARCB1 (INI-1) deficient sinonasal carcinoma: A potential diagnostic pitfall.
Allison DB; Bishop JA; Ali SZ
Diagn Cytopathol; 2016 Aug; 44(8):700-3. PubMed ID: 27177850
[TBL] [Abstract][Full Text] [Related]
10. SMARCB1 (INI-1)-Deficient Adenocarcinoma of the Sinonasal Tract: A Potentially Under-Recognized form of Sinonasal Adenocarcinoma with Occasional Yolk Sac Tumor-Like Features.
Shah AA; Jain D; Ababneh E; Agaimy A; Hoschar AP; Griffith CC; Magliocca KR; Wenig BM; Rooper LM; Bishop JA
Head Neck Pathol; 2020 Jun; 14(2):465-472. PubMed ID: 31468350
[TBL] [Abstract][Full Text] [Related]
11. High-Grade Sinonasal Carcinoma: Classification Through Molecular Profiling.
Guilmette J; Sadow PM
Arch Pathol Lab Med; 2019 Nov; 143(11):1416-1419. PubMed ID: 30779592
[TBL] [Abstract][Full Text] [Related]
12. SWI/SNF-deficient Sinonasal Carcinomas.
Agaimy A
Adv Anat Pathol; 2023 Mar; 30(2):95-103. PubMed ID: 36580412
[TBL] [Abstract][Full Text] [Related]
13. SMARCB1/INI1-deficient sinonasal carcinoma shows methylation of RASSF1 gene: A clinicopathological, immunohistochemical and molecular genetic study of a recently described entity.
Laco J; Chmelařová M; Vošmiková H; Sieglová K; Bubancová I; Dundr P; Němejcová K; Michálek J; Čelakovský P; Mottl R; Sirák I; Vošmik M; Ryška A
Pathol Res Pract; 2017 Feb; 213(2):133-142. PubMed ID: 28069272
[TBL] [Abstract][Full Text] [Related]
14. SMARCA4-deficient Sinonasal Carcinoma: A Series of 10 Cases Expanding the Genetic Spectrum of SWI/SNF-driven Sinonasal Malignancies.
Agaimy A; Jain D; Uddin N; Rooper LM; Bishop JA
Am J Surg Pathol; 2020 May; 44(5):703-710. PubMed ID: 31934917
[TBL] [Abstract][Full Text] [Related]
15. SMARCB1 (INI1)-Deficient Sinonasal Carcinoma with Yolk Sac differentiation Showing Co-loss of SMARCA4 Immunostaining - A Case Report and Literature Review.
Ng JKM; Chan JYK; Li JJX; Tang K; Yeung DCM; Chan ABW
Head Neck Pathol; 2022 Sep; 16(3):934-941. PubMed ID: 35257325
[TBL] [Abstract][Full Text] [Related]
16. Sinonasal undifferentiated carcinoma: clinicopathological spectrums and diagnosis reappraisal.
Vaziri Fard E; Zhang S; Cai Z; Ding J; Sun Q; Saluja K; Zhu H
Hum Pathol; 2019 Jul; 89():62-70. PubMed ID: 31054892
[TBL] [Abstract][Full Text] [Related]
17. [Sinonasal neoplasms: Update from the WHO 2022].
Agaimy A
Pathologie (Heidelb); 2023 Jul; 44(4):233-239. PubMed ID: 37286851
[TBL] [Abstract][Full Text] [Related]
18. SMARCB1 deficient sinonasal carcinoma: An emerging entity with a diagnostic challenge.
Anila KR; Ginju V; Vishnu VL; Kumar R; Jayasree K
Indian J Pathol Microbiol; 2023; 66(1):159-161. PubMed ID: 36656230
[TBL] [Abstract][Full Text] [Related]
19. SMARCB1-Deficient Sinonasal Carcinoma: A Case Report and Discussion of the Clinical Implications.
Trieu V; Aulet RM; Ciolino A; Rimash T
Ann Otol Rhinol Laryngol; 2019 Jul; 128(7):676-680. PubMed ID: 30873845
[TBL] [Abstract][Full Text] [Related]
20. SWI/SNF-deficient head and neck neoplasms: An overview.
Agaimy A; Bishop JA
Semin Diagn Pathol; 2021 May; 38(3):175-182. PubMed ID: 33663878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]